30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Performance

Overall performance
2.3

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
24 58% Buy
34 71% Buy
47 69% Buy

Performance for realised trades
4.4
Average return -89%
Success rate 73%
Average holding period 220
Transactions 28

Positions

Position Company Period
Director ESSA Pharma Inc Jan. 1, 2016 -
Independent Director Five Prime Therapeutics Inc Sept. 1, 2010 -
Independent Director Atreca Inc Oct. 1, 2014 -
Independent Director Proteostasis Therapeutics Inc Feb. 1, 2016 -
Independent Director Kezar Life Sciences Inc Nov. 1, 2016 -
Independent Director Immune Design Corp March 1, 2014 - April 2, 2019
Independent Director ESSA Pharma Inc March 5, 2015 - Jan. 1, 2016
Independent Director Seagen Inc June 1, 2004 - May 16, 2014
Director Lineage Cell Therapeutics Inc May 13, 2013 - March 21, 2014
Director Asterias Biotherapeutics Inc June 1, 2013 - March 21, 2014

Franklin Berger's trades of Atea Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-12 2024-12-10 S Sale
28,351 +37.3%
345.80
US$3,417,050
28,351 +37.3% 345.80 US$3,417,050
2024-12-10 2024-12-10 PrS Proposed sale
57,426
310.65
US$680,021
57,426 310.65 US$680,021
2023-11-22 2023-11-21 B Purchase
29,123 +25.2%
364.95
US$540,343
29,123 +25.2% 364.95 US$540,343
2023-11-16 2023-11-03 B Purchase
16,471 +2.2%
5.99
US$98,661
16,471 +2.2% 5.99 US$98,661
2023-11-16 2023-11-02 B Purchase
60,000 +8.8%
5.35
US$321,000
60,000 +8.8% 5.35 US$321,000
2023-01-05 2022-12-21 S Sale
34,334 -4.8%
2.42
US$83,088
34,334 -4.8% 2.42 US$83,088
2023-01-05 2022-12-21 S Sale
37,889 -5.0%
2.41
US$91,312
37,889 -5.0% 2.41 US$91,312
2023-01-05 2022-12-20 S Sale
43,617 -5.5%
2.53
US$110,351
43,617 -5.5% 2.53 US$110,351
2023-01-05 2022-12-16 S Sale
50,000 -5.9%
2.67
US$133,500
50,000 -5.9% 2.67 US$133,500
2023-01-05 2022-12-15 S Sale
50,000 -5.6%
2.86
US$143,000
50,000 -5.6% 2.86 US$143,000
2023-01-05 2022-12-15 S Sale
32,000 -3.4%
2.90
US$92,800
32,000 -3.4% 2.90 US$92,800
2023-01-05 2022-12-14 S Sale
25,000 -2.6%
3.00
US$75,000
25,000 -2.6% 3.00 US$75,000
2022-11-23 2022-11-22 B Purchase
77,000 +8.3%
8.27
US$636,790
77,000 +8.3% 8.27 US$636,790
2022-11-23 2022-11-21 B Purchase
45,000 +5.1%
7.80
US$351,000
45,000 +5.1% 7.80 US$351,000
2022-11-15 2022-11-14 S Sale
16,166 -2.0%
5.16
US$83,352
16,166 -2.0% 5.16 US$83,352
2022-11-15 2022-11-11 S Sale
25,500 -3.1%
5.15
US$131,333
25,500 -3.1% 5.15 US$131,333
2022-11-14 2022-11-08 B Purchase
42,881 +5.1%
5.83
US$249,996
42,881 +5.1% 5.83 US$249,996
2022-03-22 2022-03-21 B Purchase
20,000 +2.3%
14.77
US$295,400
20,000 +2.3% 14.77 US$295,400
2022-03-22 2022-03-18 B Purchase
45,000 +5.4%
17.00
US$765,000
45,000 +5.4% 17.00 US$765,000
2022-03-22 2022-03-18 B Purchase
15,000 +1.9%
15.96
US$239,400
15,000 +1.9% 15.96 US$239,400
2021-04-27 2021-04-23 B Purchase
5,000 +4.2%
15.78
US$78,900
5,000 +4.2% 15.78 US$78,900
2021-04-27 2021-04-23 B Purchase
120,000 +inf%
17.00
US$2,040,000
120,000 +inf% 17.00 US$2,040,000
2021-03-04 2021-02-22 B Purchase
57,000 +6.3%
27.00
US$1,539,000
57,000 +6.3% 27.00 US$1,539,000
2020-11-03 2020-11-03 B Purchase
41,666 +5.4%
24.00
US$999,984
41,666 +5.4% 24.00 US$999,984
2020-06-11 2020-06-11 B Purchase
100,000 +14.6%
5.50
US$550,000
100,000 +14.6% 5.50 US$550,000
2020-02-05 2020-02-04 B Purchase
120,846 +21.5%
2.60
US$314,200
120,846 +21.5% 2.60 US$314,200
2013-08-22 2013-08-20 B Purchase
500 +inf%
3.71
US$1,854
500 +inf% 3.71 US$1,854